Aaron Horne, MD
Cardiovascular Disease · Livingston, NJNPI 1326208620
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) at 29.3% of the total. Reporting peaked in 2019 at $37,075 and has fallen 89.4% since, to $3,921 in 2025. Among cardiovascular disease clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 469 payments — averaging $159.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$22K
- Cardiovascular Systems Inc.$16K
- Edwards Lifesciences$10K
- Pfizer$7K
- Medtronic$5K
- Abbott$3K
- plus $11K from 32 others
Across 2 payments — averaging $14,448 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cardiovascular Systems Inc.$29K
What the payments were for
- Consulting fees$6,5009%
- Speaking & faculty fees$37,05049%
- Travel & lodging$6,7659%
- Food & beverage$24,58233%
- Education$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 69 | $21,937 |
| Cardiovascular Systems Inc. | 63 | $16,426 |
| Edwards Lifesciences | 28 | $10,216 |
| Pfizer | 6 | $7,103 |
| Medtronic(2 entities) | 63 | $4,928 |
| Abbott | 44 | $3,413 |
| Biotronik Inc. | 33 | $2,946 |
| Bard Peripheral Vascular, Inc. | 13 | $2,354 |
| Philips North America LLC | 15 | $1,191 |
| Boston Scientific | 10 | $754 |
| Acist Medical Systems, Inc. | 10 | $573 |
| Cardiva Medical, Inc. | 19 | $457 |
| AstraZeneca | 14 | $331 |
| Shockwave Medical, Inc | 10 | $310 |
| Novartis | 10 | $306 |
| Penumbra, Inc. | 4 | $296 |
| Abiomed | 5 | $275 |
| Amgen | 16 | $275 |
| Chiesi USA, Inc. | 11 | $165 |
| TEI Biosciences Inc | 1 | $114 |
| Endologix LLC | 1 | $74 |
| Bardy Diagnostics, Inc. | 2 | $59 |
| Livanova USA, Inc. | 1 | $54 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| Irhythm Technologies, Inc. | 2 | $30 |
| Novo Nordisk | 2 | $28 |
| Esperion Therapeutics, Inc. | 2 | $28 |
| Merck | 2 | $26 |
| Canon Medical Systems USA, Inc. | 1 | $24 |
| Biosense Webster, Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $22 |
| Arbor Pharmaceuticals, Inc. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Surmodics, Inc. | 1 | $21 |
| Cardinal Health 200 LLC | 1 | $14 |
| Baxter Healthcare | 1 | $13 |
| Medicure Pharma Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LifeVest$19,889
- Coronary Orbital Atherectomy System$13,645
- Peripheral Orbital Atherectomy System$7,618
- VYNDAQEL$7,050
- Edwards SAPIEN 3 Transcatheter Heart Valve$6,957
- COREVALVE EVOLUT R$1,340
- MitraClip$981
- EVOQUE$931
- Confirm Rx$879
- (9520) IGT Devices Undivided$875
- SYMPLICITY G3$771
- PK Papyrus$696
- Astron; Pulsar; AstronPulsar$696
- Orsiro$696
- Pulsar$696
- PRO-Kinetic Energy$696
- ONYX FRONTIER$591
- WATCHMAN FLX$435
- Diamondback Coronary$387
- ENDURANT IIS$312
How this compares
$74,912 in reported general payments places this provider in the 95th percentile of 1,006 cardiovascular disease providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 64 | $64,642 |
| EntrestoSacubitril/Valsartan | 48 | $49,359 |
| XareltoRivaroxaban | 19 | $22,466 |
| Repatha SureclickEvolocumab | 12 | $8,718 |
| Rosuvastatin Calcium | 49 | $1,145 |
| Metoprolol Succinate | 96 | $1,114 |
| Atorvastatin Calcium | 85 | $898 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 23 | $653 |
| Amlodipine Besylate | 44 | $574 |
| ClopidogrelClopidogrel Bisulfate | 29 | $442 |
| Ezetimibe | 13 | $353 |
| Losartan Potassium | 45 | $330 |
| Lisinopril | 38 | $313 |
| Carvedilol | 27 | $278 |
| Pravastatin Sodium | 25 | $206 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $7,103 | $64,64264 claims |
| NovartisEntresto | $306 | $49,35948 claims |
| Johnson & JohnsonXarelto | $22 | $22,46619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,006 cardiovascular disease providers in New Jersey.
Other cardiovascular disease in Livingston
- Marc CohenNewark$762K
- Peter FarrugiaColts Neck$600K
- Felix Dailey-SterlingGuttenberg$568K
- Ramzan ZakirNew Brunswick$342K
- Richard KovachBrowns Mills$300K
- Andrea RussoCamden$293K
- John KostisNew Brunswick$225K
- Dilip ViswanathHaddon Heights$167K
- David PowellSpringfield$162K
- Fadi ChaabanWest Orange$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.